MedTrace Logo

Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)

NCT01310387 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2016-02-05

No results posted yet for this study

Summary

This study is:

* A single-center, randomized, prospective controlled trial.
* To prove superiority of active pain management group compared to control group by the percent of pain intensity difference of outpatients with lung cancer pain.
* 204 patients will be recruited.

Conditions

Interventions

BEHAVIORAL

Active pain management

Active pain management will be provided by specialized pain nurse, such as telephone counseling for toxicity control and opioid dose modification.

Sponsors & Collaborators

  • Janssen Korea, Ltd., Korea

    collaborator INDUSTRY

  • Chonnam National University Hospital

    lead OTHER

Principal Investigators

  • Young-Chul Kim, MD,PhD · Chonnam National University Hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-01-31
Completion
2012-06-30

Countries

  • South Korea

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01310387 on ClinicalTrials.gov